Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Organon & Co. (OGN)

Organon & Co. (OGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,686,848
  • Shares Outstanding, K 260,316
  • Annual Sales, $ 6,216 M
  • Annual Income, $ 187,000 K
  • EBIT $ 1,125 M
  • EBITDA $ 1,737 M
  • 60-Month Beta 0.60
  • Price/Sales 0.27
  • Price/Cash Flow 1.13
  • Price/Book 2.26

Options Overview Details

View History
  • Implied Volatility 54.39% (+0.16%)
  • Historical Volatility 51.40%
  • IV Percentile 40%
  • IV Rank 34.26%
  • IV High 91.71% on 11/05/25
  • IV Low 34.94% on 03/19/25
  • Expected Move (DTE 9) 0.52 (8.06%)
  • Put/Call Vol Ratio 0.85
  • Today's Volume 455
  • Volume Avg (30-Day) 1,793
  • Put/Call OI Ratio 0.78
  • Today's Open Interest 112,462
  • Open Int (30-Day) 118,685
  • Expected Range 5.91 to 6.95

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.81
  • Number of Estimates 2
  • High Estimate 0.89
  • Low Estimate 0.73
  • Prior Year 0.95
  • Growth Rate Est. (year over year) -14.74%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.34 +1.18%
on 03/10/26
8.24 -22.15%
on 02/24/26
-1.28 (-16.58%)
since 02/11/26
3-Month
6.34 +1.18%
on 03/10/26
9.94 -35.46%
on 01/23/26
-0.95 (-12.84%)
since 12/11/25
52-Week
6.18 +3.80%
on 10/30/25
15.88 -59.59%
on 03/19/25
-9.19 (-58.88%)
since 03/11/25

Most Recent Stories

More News
3 Small-Cap Stocks We Approach with Caution

3 Small-Cap Stocks We Approach with Caution

PATH : 11.86 (+2.33%)
PVH : 61.19 (-2.90%)
OGN : 6.43 (-0.77%)
New Analysis of Organon’s VTAMA® (tapinarof) cream, 1%, Phase 3 Data Showed Early and Consistent Improvement in Patient-Reported Sleep Subdomains in Pediatric Patients Down to 2 Years of Age with Atopic Dermatitis

Clinically meaningful improvements in sleep scores, as measured by subdomains of the Patient-Oriented Eczema Measure (POEM) and Dermatitis Family Impact (DFI) assessments, were observed as early as week...

OGN : 6.43 (-0.77%)
Organon Enters into Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device

MIUDELLA® is a strategic addition to Organon’s portfolio, strengthening its long‑term commitment to advancing women’s health

OGN : 6.43 (-0.77%)
5 Revealing Analyst Questions From Organon’s Q4 Earnings Call

5 Revealing Analyst Questions From Organon’s Q4 Earnings Call

OGN : 6.43 (-0.77%)
Amphastar Pharmaceuticals, Novavax, and Organon Shares Skyrocket, What You Need To Know

Amphastar Pharmaceuticals, Novavax, and Organon Shares Skyrocket, What You Need To Know

OGN : 6.43 (-0.77%)
AMPH : 18.76 (-0.79%)
NVAX : 10.53 (-1.50%)
OGN Q4 Deep Dive: Margin Compression and U.S. Headwinds Shape 2026 Outlook

OGN Q4 Deep Dive: Margin Compression and U.S. Headwinds Shape 2026 Outlook

OGN : 6.43 (-0.77%)
Organon (NYSE:OGN) Reports Q4 CY2025 In Line With Expectations

Organon (NYSE:OGN) Reports Q4 CY2025 In Line With Expectations

OGN : 6.43 (-0.77%)
Organon: Q4 Earnings Snapshot

Organon: Q4 Earnings Snapshot

OGN : 6.43 (-0.77%)
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025

Full year 2025 revenue of $6.2 billion, down 3% on both an as-reported basis and at constant currency Full year 2025 diluted earnings per share of $0.72 and non-GAAP Adjusted diluted...

OGN : 6.43 (-0.77%)
Organon Earnings: What To Look For From OGN

Organon Earnings: What To Look For From OGN

OGN : 6.43 (-0.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Organon is a healthcare company. It focuses on the health of women throughout their lives. Organon is based in JERSEY CITY, N.J.

See More

Key Turning Points

3rd Resistance Point 6.90
2nd Resistance Point 6.76
1st Resistance Point 6.62
Last Price 6.43
1st Support Level 6.34
2nd Support Level 6.20
3rd Support Level 6.06

See More

52-Week High 15.88
Fibonacci 61.8% 12.17
Fibonacci 50% 11.03
Fibonacci 38.2% 9.88
Last Price 6.43
52-Week Low 6.18

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar